Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027079
Status:
COMPLETED
Last Update Posted:
2007-12-10
First Post:
2001-11-20
Brief Title:
Combined Pharmacotherapies for Alcoholism NaltrexoneOndansetron
Sponsor:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Organization:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the effectiveness of ondansetron Zofran and naltrexone ReVia both alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics All subjects will received standardized Cognitive Behavioral Therapy Followup assessments will be completed at 1 3 6 and 9 months after treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None